Skip to main navigation
  • About
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Clinical And Scientific Advisors
    • Contact
  • Science
    • Immune Continuum
    • CCR4 in Cancer
    • CCR4 in Inflammation
    • GCN2
    • Publications
  • Pipeline
    • Snapshot
    • FLX475
    • RPT193
    • GCN2i
    • HPK1
    • Discovery Programs
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Email Alerts
    • Investor Contact
    • Investor FAQs
  • Careers
    • Culture
    • Benefits
    • Open Positions
  • Corporate Governance
  • Documents & Charters
  • Committee Composition
  • Leadership
  • Board of Directors

Documents & Charters

Documents & Charters

Governance Documents
Documents
Code of Business Conduct and Ethics
Corporate Governance Guidelines
Committee Charters
Documents
Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Shareholder tools
Print page
RSS feeds
Share page
E-mail alerts
  • Facebook1
  • LinkedIn
  • Twitter
Contact Us
+1.650.489.9000
inquiries@rapt.com
  • Home
  • About
  • Science
  • Pipeline
  • Investors
  • Careers
  • Terms of Use
  • Privacy Policy

RAPT Therapeutics, Inc.
561 Eccles Avenue
South San Francisco, CA 94080

RAPT Therapeutics, formerly known as FLX Bio.

© RAPT Therapeutics , Inc. All right reserved.